164 related articles for article (PubMed ID: 16645367)
1. Myocardial preconditioning and cardioprotection by volatile anaesthetics.
Siracusano L; Girasole V; Alvaro S; Chiavarino ND
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):86-95. PubMed ID: 16645367
[TBL] [Abstract][Full Text] [Related]
2. [Myocardial protection by volatile anesthetics].
Preckel B; Müllenheim J; Schlack W
Anaesthesiol Reanim; 2002; 27(5):116-23. PubMed ID: 12451935
[TBL] [Abstract][Full Text] [Related]
3. [Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications].
Chiari P; Bouvet F; Piriou V
Ann Fr Anesth Reanim; 2005 Apr; 24(4):383-96. PubMed ID: 15826789
[TBL] [Abstract][Full Text] [Related]
4. Ischaemic preconditioning: from molecular characterisation to clinical application--part I.
Riksen NP; Smits P; Rongen GA
Neth J Med; 2004 Nov; 62(10):353-63. PubMed ID: 15683090
[TBL] [Abstract][Full Text] [Related]
5. Inhalational anaesthetics and cardioprotection.
Weber NC; Schlack W
Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
[TBL] [Abstract][Full Text] [Related]
6. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?
Minguet G; Joris J; Lamy M
Eur J Anaesthesiol; 2007 Sep; 24(9):733-45. PubMed ID: 17555610
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury.
Ruiz-Meana M; Rodríguez-Sinovas A; Cabestrero A; Boengler K; Heusch G; Garcia-Dorado D
Cardiovasc Res; 2008 Jan; 77(2):325-33. PubMed ID: 18006437
[TBL] [Abstract][Full Text] [Related]
8. [Cardioprotection by anesthetics].
Hara T
Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
[TBL] [Abstract][Full Text] [Related]
9. Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1.
Weber NC; Toma O; Damla H; Wolter JI; Schlack W; Preckel B
Eur J Pharmacol; 2006 Jun; 539(1-2):1-9. PubMed ID: 16716295
[TBL] [Abstract][Full Text] [Related]
10. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms.
Zaugg M; Lucchinetti E; Uecker M; Pasch T; Schaub MC
Br J Anaesth; 2003 Oct; 91(4):551-65. PubMed ID: 14504159
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection by volatile anesthetics.
Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
[TBL] [Abstract][Full Text] [Related]
12. Anesthetic preconditioning confers acute cardioprotection via up-regulation of manganese superoxide dismutase and preservation of mitochondrial respiratory enzyme activity.
Chen CH; Liu K; Chan JY
Shock; 2008 Feb; 29(2):300-8. PubMed ID: 17693941
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
14. [Adaptation of myocardium to ischemia. The early phase of ischemic preconditioning].
Maslov LN; Lishmanov IuB; Solenkova NV
Usp Fiziol Nauk; 2006; 37(3):25-41. PubMed ID: 17022466
[TBL] [Abstract][Full Text] [Related]
15. Ischaemic preconditioning of the brain, mechanisms and applications.
Steiger HJ; Hänggi D
Acta Neurochir (Wien); 2007 Jan; 149(1):1-10. PubMed ID: 17151832
[TBL] [Abstract][Full Text] [Related]
16. Mapping preconditioning's signaling pathways: an engineering approach.
Downey JM; Krieg T; Cohen MV
Ann N Y Acad Sci; 2008 Mar; 1123():187-96. PubMed ID: 18375591
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
18. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
[TBL] [Abstract][Full Text] [Related]
19. Myocardial preconditioning: mechanisms and man.
Edwards RJ; Marber MS
Int J Clin Pract; 1998 Sep; 52(6):395-401. PubMed ID: 9894376
[TBL] [Abstract][Full Text] [Related]
20. Ischaemic preconditioning: from molecular characterisation to clinical application--part II.
Riksen NP; Smits P; Rongen GA
Neth J Med; 2004 Dec; 62(11):409-23. PubMed ID: 15685892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
